Cite
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.
MLA
Hui Wang, et al. “Quantification of Mutant SPOP Proteins in Prostate Cancer Using Mass Spectrometry-Based Targeted Proteomics.” Journal of Translational Medicine, vol. 15, Aug. 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12967-017-1276-7.
APA
Hui Wang, Barbieri, C. E., Jintang He, Yuqian Gao, Tujin Shi, Chaochao Wu, Schepmoes, A. A., Fillmore, T. L., Sung-Suk Chae, Huang, D., Mosquera, J. M., Wei-Jun Qian, Smith, R. D., Srivastava, S., Kagan, J., Camp II, D. G., Rodland, K. D., Rubin, M. A., Tao Liu, & Wang, H. (2017). Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics. Journal of Translational Medicine, 15, 1–10. https://doi.org/10.1186/s12967-017-1276-7
Chicago
Hui Wang, Christopher E. Barbieri, Jintang He, Yuqian Gao, Tujin Shi, Chaochao Wu, Athena A. Schepmoes, et al. 2017. “Quantification of Mutant SPOP Proteins in Prostate Cancer Using Mass Spectrometry-Based Targeted Proteomics.” Journal of Translational Medicine 15 (August): 1–10. doi:10.1186/s12967-017-1276-7.